Research at Gies

Gathering Knowledge, Powering Innovation

At Gies Business, we promise our students that an education is just the start – that here they can discover their purpose. Our faculty are at the center of that promise, guiding students to challenge assumptions, to be inventive, and to develop their own style. Our exceptional faculty conduct cutting-edge research that regularly impacts industry and helps business decisions get made.

Business Research Lab

The Business Research Lab at Gies College of Business is dedicated to supporting Gies faculty in performing groundbreaking research on business decision making. Gies faculty are among the top researchers in the world. We are focused on addressing critical societal needs through the transfer and application of knowledge, and we are committed to fostering industry-leading research than can help organizations and individuals make effective, efficient decisions. Your participation in research helps us create knowledge that can enhance the worldwide reputation of the University of Illinois as a premier research institution and shape the future decision-making practices of businesses and organizations around the world. 

 
Margolis Lab

Join Our Research Panel

As part of the Business Research Lab panel, you would be invited to participate periodically in research studies on topics in accounting, organizational management, or marketing. Participating in Gies research is voluntary and can be done on your own schedule, as often as you’d like.  For more information, contact Jen Themanson, Coordinator, at busresearchlab@illinois.edu.

Research Stories

Timely preventative efforts better than mitigation during early stages of outbreak

Apr 2, 2020, 12:00 PM by Aaron Bennett
During the early stages of an infectious disease outbreak, channeling resources toward prevention bests mitigation or curative efforts, according to Gies professor.

During the early stages of an infectious disease outbreak, channeling resources toward the prevention of disease spread through testing, identification, and quarantine activities bests mitigation or curative efforts, according to a new working paper co-written by a Gies College of Business expert who studies innovation in health care and supply chain logistics.

Ujjal Mukherjee 13Epidemics such as COVID-19 are characterized by resource constraints due to sudden and unprecedented demand shocks for health care facilities, equipment, and consumables such as medical supplies including gloves, masks, and surgical gowns. All of those variables combined make the proper allocation of available preventative resources all the more important to blunt the pathogen’s spread, said Ujjal Kumar Mukherjee, a professor of business administration at Gies College of Business at the University of Illinois at Urbana-Champaign. 

“The COVID-19 outbreak has left the global community reeling and struggling for an adequate response,” Mukherjee said. “The objective of preventative actions is to bring down and maintain the ‘basic reproduction number,’ which is the ratio of the rate of spread to the rate of recovery, below a value of one. If the basic reproduction number is above one, then the disease spreads rapidly, almost exponentially, and can engulf a large population. We show that if you delay preventative actions such as quarantine and isolation, that only serves to exponentially increase the future cost of disease management.”

Mukherjee and his co-author Karthik Natarajan (University of Minnesota) used data from the 2014-15 Ebola outbreak in West Africa to analyze strategies for resource allocation for epidemic management. They find that any delay in adopting adequate preventative actions increases the total disease burden as well as the aggregate social and economic costs of the disease.

“We first derive theoretical insights using an analytical model based on the popular ‘susceptible-infectious-recovered’ model for epidemic dynamics,” Mukherjee said. “Some of the important aspects that drive the insights are the infection propagation rates, recovery rates, availability of standard of care, and the extent of initial spread when the disease gets recognized as an epidemic.”

Other important factors include population density of epicenters of spread; mobility of populations to and from the epicenters; and the gestation period of disease infection, “when infective persons are capable of transmitting but are not detectable, or detected and not isolated, which is something we’re seeing a lot of with COVID-19,” Mukherjee said.

Since population-level preventative actions of isolation are expensive in terms of direct and indirect costs of economic productivity loss, deciding the optimal levels of preventative actions in a timely manner is critical, Mukherjee said.

“We also show that the optimal levels of preventative actions increase exponentially with an increase in population density due to underdeveloped community immunity or unavailability of proven cure,” he said.

Furthermore, the presence of a potentially large number of undetected infective populations who can be unknowing transmitters of the disease when in close contact with a susceptible population necessitates significant global isolation initiatives such as the creation of isolation zones or limiting the mobility of populations with high infection load.

“It’s not until the infection spread is controlled using preventative measures, and there is a large number of recovered populations with natural immunity, that the focus can shift to recovery actions,” Mukherjee said.

According to Mukherjee, the takeaways from the Ebola epidemic are wholly relevant and applicable to the current COVID-19 outbreak.

“The resource crunch in terms of medical supplies argues for the necessity to adopt higher levels of preparedness-related measures for future occurrences of similar episodes,” he said. “Maintaining a national inventory of essential supplies such as masks, medical gloves and basic medication – that’s the first line of action. But due to uncertainty in timing and spatial location of epidemics such as COVID-19, measures such as obsolescence and replacement strategy of epidemic safety-net inventory, inventory aggregation and inventory sharing contracts at national or even at international levels would be equally as important.

“For capital equipment such as medical devices like ventilators, the creation of buffer capacity in the medical device manufacturing system that can be activated on short notice is imperative.”

But with COVID-19, the estimated initial disease load in society at detection is relatively higher compared with Ebola, Mukherjee said.

“That makes the early preventative measures such as social distancing and community-level isolation measures play a more significant role in controlling the spread of COVID-19,” he said. “Once these measures have resulted in reducing transmission rates below one, the focus can be diverted to recovery efforts. At every stage of an epidemic, both preventative and recovery actions are required, but the relative importance of the two changes significantly at different stages of an outbreak.

“Since most outbreaks are characterized by a lack of readily available treatment or vaccination options, prompt and optimal response can go a long way in minimizing loss to human life.”

Editor’s notes: To contact Ujjal Kumar Mukherjee, call 217-265-5565; email ukm@illinois.edu.

The paper “Optimal allocation and usage of funding for management of infectious disease outbreaks” is available from the News Bureau.

SHOW ALL RESEARCH